Brown Advisory Inc. Sells 2,307 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Brown Advisory Inc. lessened its position in Stericycle, Inc. (NASDAQ:SRCL) by 16.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,380 shares of the business services provider’s stock after selling 2,307 shares during the period. Brown Advisory Inc.’s holdings in Stericycle were worth $564,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in SRCL. Private Advisor Group LLC raised its holdings in shares of Stericycle by 8.6% during the fourth quarter. Private Advisor Group LLC now owns 5,788 shares of the business services provider’s stock valued at $287,000 after purchasing an additional 459 shares during the last quarter. Barclays PLC increased its holdings in Stericycle by 30.6% during the third quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock valued at $3,147,000 after buying an additional 16,505 shares during the last quarter. Robeco Institutional Asset Management B.V. purchased a new stake in Stericycle during the fourth quarter valued at approximately $156,000. Earnest Partners LLC increased its holdings in Stericycle by 6.6% during the third quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock valued at $86,793,000 after buying an additional 120,852 shares during the last quarter. Finally, Pathstone Family Office LLC purchased a new stake in Stericycle during the third quarter valued at approximately $230,000. Institutional investors own 98.82% of the company’s stock.

Stericycle Trading Up 15.4 %

Shares of NASDAQ:SRCL opened at $51.65 on Monday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a fifty day moving average price of $49.10 and a 200 day moving average price of $48.95. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm had revenue of $664.90 million during the quarter, compared to analyst estimates of $676.42 million. During the same quarter in the prior year, the business earned $0.49 earnings per share. Stericycle’s revenue for the quarter was down 2.8% on a year-over-year basis. On average, equities analysts forecast that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on SRCL shares. Wells Fargo & Company upped their target price on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a report on Friday, March 1st. Robert W. Baird dropped their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research report on Friday, April 26th. Truist Financial dropped their price target on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a research report on Monday, April 29th. Royal Bank of Canada reiterated an “outperform” rating and issued a $69.00 price target on shares of Stericycle in a research report on Thursday, March 7th. Finally, Stifel Nicolaus upped their price target on shares of Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Stericycle currently has a consensus rating of “Hold” and an average price target of $59.40.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.